aMoon is a leading healthtech & life sciences venture capital firm.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 9, 2022
Ibex Medical Analytics
|
Debt Financing | $10M | Analytics | — |
May 31, 2022
Ultima Genomics
|
Series Unknown | $600M | Biotechnology | — |
May 31, 2021
DayTwo
|
Series B | £26.30M | Health Care | — |
Mar 23, 2021
Absci
|
Series Unknown | $125M | Artificial Intelligence | — |
Mar 9, 2021
Ibex Medical Analytics
|
Series B | $38M | Analytics | — |